Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03621423
Other study ID # 0017-17-LOE
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date August 1, 2020

Study information

Verified date August 2018
Source Loewenstein Hospital
Contact Ifat Sandler, MD
Phone 97297709143
Email IfatSa2@clalit.org.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to describe the efficacy of a new approach to the subscapularis muscle under US guidance for the injection of botulinum toxin in patients that underwent a stroke suffering from hemiplegic shoulder pain.

Pain and spastic shoulder are common findings in hemiplegic patients following a stroke.

The pain interferes with rehabilitation prolonging hospitalization and is related with decreased quality of life.

There is a close relationship between spasticity of the subscapularis muscle and pain The patients show a clinical picture of adduction and internal rotation of the shoulder, elbow and wrist and fingers flexion with a limited external rotation of the shoulder.

The investigators suggest that paralyzing the subscapularis muscle with botulinum toxin may alleviate pain in the hemiplegic shoulder. Best produced when injected in a specific area of the muscle where a higher concentration of motor points exists.


Description:

Treatment using injection of botulinum toxin to the subscapularis spastic muscle has been described in the literature and is a common practice in hemiplegic shoulder. The Injection technic in this pathology is described by using anatomical landmarks of the shoulder region without using medical imaging.

On the other hand, injections to the subscapularis muscle has also been described using ultrasound guidance but not for this specific pathology.

There are no evidence-based guidelines describing us guided spastic subscapularis muscle injection. Injecting this muscle while in its spastic state requires a modulated approach Harrison et.al described cadaveric dissections of the subscapularis muscle and proposed a technique to reach the motor point zone of this muscle In our study the investigators follow the injection description published by Dong Wook Rha on cadavers based on Harrison's lateral approach description. The Ultrasound enables a correct identification of the target muscle avoiding possible complication of vessel or pulmonary puncture In our study the investigators will try to prove the efficacy of the lateral approach to the subscapularis muscle using ultrasound and nerve stimulator


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date August 1, 2020
Est. primary completion date August 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 88 Years
Eligibility Inclusion Criteria:

Post stroke patients

- Complaints of pain in hemiplegic shoulder

- Spasticity of subscapularis muscle

- Coherent

- Hebrew speakers

Exclusion Criteria:

- Aphasia

- Allergy to botulinum toxin

- Pregnant women

Study Design


Intervention

Procedure:
ultrasound guided injection
Patient will be positioned lying on side with the hemiplegic side up. The shoulder will be placed in a flexion and external rotation/abduction position, as possible by the patient, to give the ultrasound probe access to the posterior axillary fold. As previously described in the literature, a line of best fit was calculated by bisection of hypothetical line connecting the inferior spine and the acromial tip, an 18-gauge, 10-cm needle will be inserted under direct ultrasound guidance and by a nerve stimulation . After placing the needle tip in the target point's 100 units of botulinum toxin will be injected.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Loewenstein Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary The Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity.
0: No increase in muscle tone
1: Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension
1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM
2: More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved
3: Considerable increase in muscle tone, passive movement difficult
4: Affected part(s) rigid in flexion or extension
The MAS will be assessed twice: the first time before the injection and the second time, in order to assess change from baseline measure, two weeks following the injection
Secondary The Fugl-Meyer Assessment (FMA) a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 226. The FMA will be assessed twice: the first time before the injection and the second time two weeks following the injection
Secondary Visual Analogue Scale (VAS) a measurement instrument that tries to measure the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain (0-10). The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations. The VAS will be assessed twice: the first time before the injection and the second time two weeks following the injection
Secondary The Brief Pain Inventory - Short Form (BPI-sf) a 9 item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The patient is asked to rate their worst, least, average, and current pain intensity, list current treatments and their perceived effectiveness, and rate the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on a 10 point scale. The BPI-sf will be assessed twice: the first time before the injection and the second time two weeks following the injection
See also
  Status Clinical Trial Phase
Terminated NCT04113525 - Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke N/A
Completed NCT04613661 - Inter-rater Reliability of the Australian Spasticity Assessment Scale (ASAS) in Post-stroke Spasticity
Completed NCT03321097 - Condensed and Distributed Robotic Therapy in Spastic Stroke Post Botulinum Toxin Injection N/A
Completed NCT03788629 - THE EFFECTS OF SUBTALAR JOINT MOBILIZATION ON PATIENTS WITH CHRONIC STROKE N/A
Completed NCT03807557 - Robotic Modified Constraint -Induced Therapy in Patients With Spastic Hemiplegic Stroke Post Botulinum Toxin A Injection N/A
Completed NCT04939493 - Use of Rhythmic Auditory Cueing During Bilateral Training of the Upper Extremities in Stroke Patients N/A
Recruiting NCT05557305 - Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy N/A
Completed NCT05889026 - The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity N/A
Completed NCT01336517 - Evaluation of the Effect of an Ankle Foot Orthoses for Ambulatory Function N/A
Recruiting NCT05683158 - Compensatory Kinematic Movements in Various Directions After Stroke
Recruiting NCT05767437 - The Effects of Reaching Task Following Selective Trunk Stability Exercise N/A
Completed NCT04826900 - Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection N/A